The MORENA Registry is the first head-to-head comparison of the ACURATE neo and SAPIEN 3 Aortic Valve Systems. This study evaluated device failure and early safety of both devices at 30 days. Observational 1:2 propensity-matched multicenter comparison of ACURATE neo (n = 311) and SAPIEN 3 (n = 622) from three high-volume centers in Germany.
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Mortality and Safety at 30 days
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